“…Conducting post-bronchodilator casefinding would also increase the training required, the need for clinical supervision, and the cost. 6 This would potentially reduce the utility of the test. Indeed, since the UK National Institute of Health and Clinical Excellence (NICE) guideline for COPD 13 advocates opportunistic case-finding conducted in 'at risk' populations, the case-finding test would need to be available for use at general practice facilities, smoking cessations clinics or local pharmacies.…”